Stock Price
1,884.70
Daily Change
-21.10 -1.11%
Monthly
12.95%
Yearly
10.36%
Q2 Forecast
1,838.01

Sun Pharmaceuticals reported INR147.99B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Aspen Pharmacare ZAR 17.08B 4.32B Dec/2025
Bharat Petroleum INR 1.24T 150B Mar/2026
Cipla INR 65.41B 9.77B Mar/2026
Dr.Reddys Laboratories INR 75.46B 11.81B Mar/2026
Jiangsu Hengrui CNY 8.14B 300M Mar/2026
Sh Fosun Pharma CNY 10.07B 260M Dec/2026
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
UPL INR 183.35B 59.74B Mar/2026